NRS 639.2623
Authority
- requirements to enter into collaborative practice agreement
- duties of pharmacist
- patient consent required
- conditions and limitations.
1.
Except as otherwise provided in subsection 5, a pharmacist who has entered into a valid collaborative practice agreement may engage in the collaborative practice of pharmacy or collaborative drug therapy management at any location in this State.2.
To enter into a collaborative practice agreement, a practitioner must:(a)
Be licensed in good standing to practice his or her profession in this State;(b)
Agree to maintain an ongoing relationship with a patient who is referred by the practitioner to a pharmacist pursuant to a collaborative practice agreement for collaborative drug therapy management;(c)
Agree to obtain the informed, written consent from a patient who is referred by the practitioner to a pharmacist pursuant to a collaborative practice agreement for collaborative drug therapy management; and(d)
Except as otherwise provided in this paragraph, actively practice his or her profession within 100 miles of the primary location where the collaborating pharmacist practices in this State. A practitioner and pharmacist may submit a written request to the Board for an exemption from the requirements of this paragraph. The Board may grant such a request upon a showing of good cause.3.
A pharmacist who engages in the collaborative practice of pharmacy shall:(a)
Except as otherwise provided in paragraph (b), document any treatment or care provided to a patient pursuant to a collaborative practice agreement after providing such treatment or care in the medical record of the patient, on the chart of the patient or in a separate log book;(b)
Document in the medical record of the patient, on the chart of the patient or in a separate log book any decision or action concerning the management of drug therapy pursuant to a collaborative practice agreement after making such a decision or taking such an action;(c)
Maintain all records concerning the care or treatment provided to a patient pursuant to a collaborative practice agreement in written or electronic form for at least 7 years;(d)
Comply with all provisions of the Health Insurance Portability and Accountability Act of 1996, Public Law 104-191, the regulations adopted pursuant thereto, and all other federal and state laws and regulations concerning the privacy of information regarding health care; and(e)
Provide a patient with written notification of:(1)
Any test administered by the pharmacist and the results of such a test;(2)
The name of any drug or prescription filled and dispensed by the pharmacist to the patient; and(3)
The contact information of the pharmacist.4.
A pharmacist shall obtain the informed, written consent of a patient before engaging in the collaborative practice of pharmacy on behalf of the patient. Such written consent must include, without limitation, a statement that the pharmacist:(a)
May initiate, modify or discontinue the medication of the patient pursuant to a collaborative practice agreement;(b)
Is not a physician, osteopathic physician, advanced practice registered nurse or physician assistant; and(c)
May not diagnose.5.
A practitioner may not enter into a collaborative practice agreement with a pharmacist for the management of controlled substances.6.
A pharmacy must not require a registered pharmacist, as a condition of employment, to enter into a collaborative practice agreement.
Source:
Section 639.2623 — Authority; requirements to enter into collaborative practice agreement; duties of pharmacist; patient consent required; conditions and limitations., https://www.leg.state.nv.us/NRS/NRS-639.html#NRS639Sec2623.